Cargando…

Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia

BACKGROUND AND AIM: The use of complementary and alternative medicine (CAM) is unexplored among Saudi rheumatoid arthritis (RA) patients. The aim of this study was to estimate the prevalence and types of CAM used among patients with RA and factors associated with their use. EXPERIMENTAL PROCEDURE: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Almuhareb, Aseel M., Alhawassi, Tariq M., Alghamdi, Ahmed A., Omair, Mohammed A., Alarfaj, Hussain, Alarfaj, Abdulrahman, Alomari, Bedor A., Alblowi, Maysoon S., Almalag, Haya M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978619/
https://www.ncbi.nlm.nih.gov/pubmed/31997900
http://dx.doi.org/10.1016/j.jsps.2019.07.002
_version_ 1783490736343220224
author Almuhareb, Aseel M.
Alhawassi, Tariq M.
Alghamdi, Ahmed A.
Omair, Mohammed A.
Alarfaj, Hussain
Alarfaj, Abdulrahman
Alomari, Bedor A.
Alblowi, Maysoon S.
Almalag, Haya M.
author_facet Almuhareb, Aseel M.
Alhawassi, Tariq M.
Alghamdi, Ahmed A.
Omair, Mohammed A.
Alarfaj, Hussain
Alarfaj, Abdulrahman
Alomari, Bedor A.
Alblowi, Maysoon S.
Almalag, Haya M.
author_sort Almuhareb, Aseel M.
collection PubMed
description BACKGROUND AND AIM: The use of complementary and alternative medicine (CAM) is unexplored among Saudi rheumatoid arthritis (RA) patients. The aim of this study was to estimate the prevalence and types of CAM used among patients with RA and factors associated with their use. EXPERIMENTAL PROCEDURE: A cross-sectional study was conducted at rheumatology clinics in two tertiary hospitals located in Riyadh, Saudi Arabia. The data was collected between May 2017 and February 2018. Unpaired Student's t-tests, Chi-square tests, and Pearson correlation tests were used to compare users vs nonusers. RESULTS: A total of 438 patients (mean age = 49, SD ± 15 years; 89.7% females) were included in this study. Sixty seven percent of included patients had used CAM for their RA. The majority of CAM users were female (92.1%). The most frequently used CAM products were vitamin D (47%), calcium (37%), honey (15%), ginger (13%), turmeric (11%), black seeds (8%), and fenugreek (8%). One hundred ninety-six (45%) patients believe that CAM is safe, and 287 (96%) patients took it because they believed that CAM had “added benefits”. Statistically significant differences were found for gender, RA duration, erythrocyte sedimentation rate (ESR) level, and seropositivity between CAM users and nonusers (P = 0.019, P = 0.011, P = 0.022, and P < 0.0001, respectively). A significant correlation was found between the Erythrocyte Sedimentation Rate (ESR) level, RA duration and CAM use (r = 0.110, P = 0.022 and r = 0.121, P = 0.012, respectively). These data indicated that patients who used CAM had higher ESR level and longer disease duration than patients didn’t use CAM. CONCLUSION: There is a high prevalence of CAM use among RA patients. CAM use was perceived to add benefit and patients using it had higher ESR. Larger studies are needed to assess the use of CAM and its impact on RA and its management.
format Online
Article
Text
id pubmed-6978619
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69786192020-01-29 Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia Almuhareb, Aseel M. Alhawassi, Tariq M. Alghamdi, Ahmed A. Omair, Mohammed A. Alarfaj, Hussain Alarfaj, Abdulrahman Alomari, Bedor A. Alblowi, Maysoon S. Almalag, Haya M. Saudi Pharm J Article BACKGROUND AND AIM: The use of complementary and alternative medicine (CAM) is unexplored among Saudi rheumatoid arthritis (RA) patients. The aim of this study was to estimate the prevalence and types of CAM used among patients with RA and factors associated with their use. EXPERIMENTAL PROCEDURE: A cross-sectional study was conducted at rheumatology clinics in two tertiary hospitals located in Riyadh, Saudi Arabia. The data was collected between May 2017 and February 2018. Unpaired Student's t-tests, Chi-square tests, and Pearson correlation tests were used to compare users vs nonusers. RESULTS: A total of 438 patients (mean age = 49, SD ± 15 years; 89.7% females) were included in this study. Sixty seven percent of included patients had used CAM for their RA. The majority of CAM users were female (92.1%). The most frequently used CAM products were vitamin D (47%), calcium (37%), honey (15%), ginger (13%), turmeric (11%), black seeds (8%), and fenugreek (8%). One hundred ninety-six (45%) patients believe that CAM is safe, and 287 (96%) patients took it because they believed that CAM had “added benefits”. Statistically significant differences were found for gender, RA duration, erythrocyte sedimentation rate (ESR) level, and seropositivity between CAM users and nonusers (P = 0.019, P = 0.011, P = 0.022, and P < 0.0001, respectively). A significant correlation was found between the Erythrocyte Sedimentation Rate (ESR) level, RA duration and CAM use (r = 0.110, P = 0.022 and r = 0.121, P = 0.012, respectively). These data indicated that patients who used CAM had higher ESR level and longer disease duration than patients didn’t use CAM. CONCLUSION: There is a high prevalence of CAM use among RA patients. CAM use was perceived to add benefit and patients using it had higher ESR. Larger studies are needed to assess the use of CAM and its impact on RA and its management. Elsevier 2019-11 2019-07-08 /pmc/articles/PMC6978619/ /pubmed/31997900 http://dx.doi.org/10.1016/j.jsps.2019.07.002 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Almuhareb, Aseel M.
Alhawassi, Tariq M.
Alghamdi, Ahmed A.
Omair, Mohammed A.
Alarfaj, Hussain
Alarfaj, Abdulrahman
Alomari, Bedor A.
Alblowi, Maysoon S.
Almalag, Haya M.
Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title_full Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title_fullStr Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title_full_unstemmed Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title_short Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
title_sort prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in saudi arabia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978619/
https://www.ncbi.nlm.nih.gov/pubmed/31997900
http://dx.doi.org/10.1016/j.jsps.2019.07.002
work_keys_str_mv AT almuharebaseelm prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alhawassitariqm prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alghamdiahmeda prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT omairmohammeda prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alarfajhussain prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alarfajabdulrahman prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alomaribedora prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT alblowimaysoons prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia
AT almalaghayam prevalenceofcomplementaryandalternativemedicineuseamongrheumatoidarthritispatientsinsaudiarabia